Novo NordiskNovo NordiskNovo buys again: 5-billion-dollar deal for Akero´s MASHNovo Nordisk is to acquire US-based Akero Therapeutics in a US$5.2 billion deal aimed at reviving growth and entering the MASH-space where others like Roche and GSK have recently expanded their foot … more ➔
AseBioEventBioSpain 2025 starts with new recordsBioSpain 2025 opened in Barcelona, the capital of Catalonia, setting a new record for both visitors and exhibitors. During the inauguration, representatives from government and industry highlighted the … more ➔
Pixabay.comHeart failureEuphoria in Milan: Italian Nanophoria closes €83m financing round in heart failureItalian NanoPhoria Bioscience raises surprisingly high €83.5 million to advance novel heart failure therapy with a very early non clinical asset. more ➔
Owlstone Medical Ltd.CancerBritish Owlstone Medical wins ARPA-H award, but will it materialize?Owlstone Medical, a pioneer in breath-based diagnostics from Cambridge (UK), has been awarded up to US$49.1m by the U.S. health innovation agency ARPA-H under its POSEIDON programme. The funding backs … more ➔
Roche Diagnostics InternationalAIRoche gets CE mark for chronic kidney disease algorithmRoche Diagnostics and its partner KlinRisk Inc have received the EU CE mark for the very first AI-based risk stratification tool that reliably assesses progressive decline in kidney function. more ➔
PharmaMar SALung cancerFDA approves atezolizumab–lurbinectedin for ES-SCLCThe U.S. FDA has approved atezolizumab and atezolizumab with hyaluronidase in combination with lurbinectedin as the first and only first-line maintenance therapy for adults with extensive-stage small … more ➔
U.S. Department of CommerceUS trade policyPharma Tariffs: US Government backtracksAfter the surprising announcement of a 100% tariff on all prescription drugs imported into the United States, the US government appears to be backtracking. Within a few days, its trade policy stance … more ➔
Rezon BioContract ManufacturingBiologics CDMO Rezon Bio leaves stealth modeRezon Bio has launched as a European contract development and manufacturing organisation (CDMO) for biologics. The new company has been created following the demerger of Polpharma Biologics into two … more ➔
Merus NVM&AGenmab swallows Merus in US$8bn dealDanish Genmab A/S has acquired the Dutch oncology specialist Merus NV for US$8bn in cash. The 41% premium over Merus’s share price at Friday is largely attributed to the bispecific EGFR x LGR5 antibody, … more ➔
Adobe stock photos - Alernon77 Licence dealMSD Secures Option on EVX-B3Danish Evaxion A/S hat optionally licenced its vaccine EVX-B3.developed with its AI-Immunology™ platform to Merck, Sharp & Dohme. MSD payed UIS$7.5m upfront and offers up to US$592m in milestone payments … more ➔
Novo Nordisk
AseBio
Pixabay.com
Owlstone Medical Ltd.
Roche Diagnostics International
PharmaMar SA
U.S. Department of Commerce
Rezon Bio
Merus NV
Adobe stock photos - Alernon77